How Fast Does Wegovy Work for Weight Loss

Early appetite changes typically appear in weeks one to two; most visible weight loss builds from month two onwards.
The licensed maintenance dose is 2.4mg weekly (with a 7.2mg option now available); reaching it takes roughly four to five months of dose titration by your prescriber.
STEP 1 trial results: roughly 15% average body-weight reduction over 68 weeks at the 2.4mg maintenance dose.
Progress varies between individuals — weight-related conditions, starting point, lifestyle and how well the dose is tolerated all affect the pace.

Most people notice the first effects of Wegovy within the initial one to two weeks, though meaningful weight loss typically builds across several months. Semaglutide, the active ingredient, begins reducing appetite almost immediately after the first dose — but the scale responds more slowly. Clinical trials published in the New England Journal of Medicine (STEP 1) found that adults using semaglutide 2.4mg lost an average of around 15% of body weight over 68 weeks. That timeline matters: Wegovy is a long-acting weekly injection, not a quick fix, and results accumulate progressively as the dose is titrated and the body adapts. As a prescription-only medicine, it is only available following clinical assessment by a registered prescriber who judges whether it is appropriate for you.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

A Practical Month-by-Month Timeline of Wegovy Weight Loss

Step 1, Weeks 1 to 4: settling in, not slimming down

The starter dose is 0.25mg, and its job is adjustment, not weight loss. Your body is learning to work with a new signal. Appetite can dip noticeably even at this stage, some people find meals feel smaller, snacking drops off, and hunger arrives later in the day. The scale may barely shift, or not at all. That is expected.

Side effects are most likely to show up now: nausea, occasional vomiting, loose stools or constipation. They cluster around the time of each injection and usually settle within a few days. Staying hydrated and eating smaller, lower-fat meals helps most people through this phase. If you want to understand how the general semaglutide timeline for weight loss compares across injection and tablet forms, that page covers the broader picture.

Your prescriber, not you, decides when and whether to move to the next dose level. At a minimum, four weeks pass at each rung before any increase.

Step 2, Months 2 to 4: the dose climbs and weight starts to move

Doses step up through 0.5mg, then 1.0mg, then 1.7mg on a roughly monthly schedule managed by your prescriber. This is when most people see the scale responding in a way that feels real. Appetite suppression deepens. Food noise (the constant low-level thinking about eating) often quietens substantially, which many patients say surprises them more than the weight change itself.

By the end of month three, a loss of around 5 to 8% of starting body weight is broadly consistent with trial data, though the range is wide. If you are curious about how long Wegovy takes to work for weight loss, that page breaks down the evidence across the full treatment timeline in more detail. Factors including starting BMI, physical activity and any weight-related conditions affect the pace.

The second-month results page goes into more detail on what the evidence shows at this specific point in treatment. The key practical point is that dose titration is non-negotiable, rushing it increases the risk of side effects without improving outcomes.

Step 3, Month 5 onwards: maintenance dose and the bulk of results

Reaching 2.4mg weekly is the standard clinical endpoint for most people on the original Wegovy pathway. From here, weight loss continues but the pace gradually slows as the body approaches a new equilibrium. The largest and most sustained losses come to people who keep the dose steady, maintain lifestyle changes and stay under regular clinical review.

The MHRA approved a higher 7.2mg maintenance dose in January 2026, and a dedicated single-dose pen for it followed in April 2026. Trials at this dose reported average weight loss of around 20.7% over 72 weeks, narrowing the gap with tirzepatide. Not everyone will reach 7.2mg; clinical assessment determines the right endpoint. For a fuller overview of the treatment, the Wegovy treatment page covers licensing, eligibility and what the prescription process involves.

NICE guidance on semaglutide (published as TA875) recommends continuing treatment only while it is producing meaningful results. If weight loss falls below 5% after six months at the maintenance dose, continuing should be reviewed with a prescriber. That review point is not a failure, it is the system working as intended.

What affects how fast Wegovy works for you specifically

Speed of response is genuinely individual. Starting BMI plays a role: people with a higher starting point tend to see larger absolute losses in the early months, though percentage changes vary. If you want a detailed look at how quickly Wegovy works for weight loss, that page examines the factors that shape individual response in depth. Strength or resistance activity helps preserve lean mass during rapid weight loss, which matters for long-term metabolic health.

Medical history matters too. Certain medicines interact with semaglutide. Oral contraceptives may be affected because GLP-1 treatment slows gastric emptying, and the NHS England guidance on weight management injections covers specific advice around contraception and HRT for people starting this treatment.

Practical consistency also adds up. Wegovy is injected once weekly, same day each week, rotating between the abdomen, thigh and upper arm. Missing doses or inconsistent timing disrupts the steady-state levels that make the medicine effective, and reading about how fast Wegovy works can help set realistic expectations around what consistent dosing actually delivers. Your pen arrives in plain, unbranded packaging (tracked by DPD) so there is nothing that draws attention; consistency is down to building a weekly habit rather than chasing a delivery.

If you are considering starting treatment or want to understand whether Wegovy is the right fit given your timeline expectations, exploring weight-loss treatment options is a sensible first step, or you can check the general FAQs for common questions about the process.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions